logologo
QuantliQuantli

BridgeBio Pharma Inc

BBIO

NASDAQ

Biotechnology

$79.86

USD

-1.35 (-1.66%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $15.84B

Volume 3.1M

Price Target

$82.00$120.00

USD

The 6 analysts offering 1-year price forecasts have a max estimate of $120.00 and a min estimate of $82.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$100.33

-$2.3 vs prior

Implied Upside

+25.6%

-2.9% vs prior

Analyst Covering

6

-2 vs prior period

Consensus

Buy

Declined vs prior

Signal Quality

Consensus Freshness

43%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0.3300 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

5 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

5

Hold

1

Sell

0

Strong Sell

0

6 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Derek Archila

Wells Fargo

Buy

Maintained

5 days ago

Plus
Plus
Plus

Raghuram Selvaraju

HC Wainwright & Co.

Buy

Maintained

4 weeks ago

Plus
Plus
Plus

Salim Syed

Mizuho

Buy

Maintained

2 months ago

Plus
Plus
Plus

Whitney Ijem

Canaccord Genuity

Buy

Initiated

2 months ago

Plus
Plus
Plus

Sean Laaman

Morgan Stanley

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

NBIX

Neurocrine Biosciences Inc

$152.72

+1.3%

UTHR

United Therapeutics Corp

$499.73

-0.3%

BMRN

BioMarin Pharmaceutical Inc

$67.36

-1.7%

ARWR

Arrowhead Pharmaceuticals Inc

$86.64

+1.2%

MRNA

Moderna Inc

$63.32

-0.5%

EXEL

Exelixis Inc

$51.24

+1.2%

MDGL

Madrigal Pharmaceuticals Inc

$507.56

+0.0%

INCY

Incyte Corp

$120.16

-0.3%

INSM

Insmed Inc

$123.74

-2.0%